These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 2891635

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Value of subcutaneous and intravenous pulsatile gonadotropin releasing hormone in polycystic ovary disease.
    Saffan DS, Seibel MM.
    J Reprod Med; 1992 Jun; 37(6):545-51. PubMed ID: 1619610
    [Abstract] [Full Text] [Related]

  • 5. Ovulation induction with pulsatile administration of human menopausal gonadotropin.
    Koloszár S, Bártfai G, Godó G, Sas M.
    Acta Chir Hung; 1989 Jun; 30(3):237-42. PubMed ID: 2512754
    [Abstract] [Full Text] [Related]

  • 6. [Ovulation induction with pulsatile gonadotropin-releasing hormone and continuous human menopausal gonadotropin in polycystic ovarian disease].
    Kuroda G.
    Nihon Naibunpi Gakkai Zasshi; 1987 Mar 20; 63(3):247-59. PubMed ID: 3111899
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Ovulation induction with a combination of LHRH analogue and hMG pulsatile subcutaneous administration in PCO patients].
    Nakamura Y, Yoshimura Y, Tamaoka Y, Yamada H, Iizuka R, Suzuki M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Dec 20; 39(12):2157-64. PubMed ID: 3123581
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clomiphene citrate-resistant polycystic ovary syndrome. Preventing multifollicular development.
    Ergür AR, Yergök YZ, Ertekin A, Küçük T, Müngen E, Tütüncü L.
    J Reprod Med; 1998 Mar 20; 43(3):185-90. PubMed ID: 9564642
    [Abstract] [Full Text] [Related]

  • 13. Daily or alternate-day FSH therapy in patients with polycystic ovarian disease resistant to clomiphene citrate treatment.
    McFaul PB, Traub AI, Sheridan B, Leslie H.
    Int J Fertil; 1989 Mar 20; 34(3):194-8. PubMed ID: 2567714
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical and endocrine response to pulsatile intravenous gonadotropins in refractory anovulation.
    Yuen BH, Pride SM, Callegari PB, Leroux AM, Moon YS.
    Obstet Gynecol; 1989 Nov 20; 74(5):763-8. PubMed ID: 2510103
    [Abstract] [Full Text] [Related]

  • 16. Treatment of polycystic ovarian disease by inducing ovulation with pulsatile subcutaneous administration of human menopausal gonadotrophin associated with luteinizing hormone-releasing hormone analogue.
    Nakamura Y, Yoshimura Y, Tamaoka Y, Ubukata Y, Yoshida K, Yamada H, Iizuka R, Suzuki M.
    Clin Endocrinol (Oxf); 1988 Oct 20; 29(4):395-402. PubMed ID: 3150824
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Induction of ovulation with pulsatile subcutaneous administration of human menopausal gonadotropin in patients with polycystic ovary syndrome.
    Nakamura Y, Yamada H, Yoshida K, Manno T, Ubukata Y, Suzuki M, Yoshimura Y.
    Horm Res; 1990 Oct 20; 33 Suppl 2():43-8. PubMed ID: 2128881
    [Abstract] [Full Text] [Related]

  • 19. Pharmaco-dynamics of human menopausal gonadotrophin (HMG) and follicle-stimulating hormone (FSH). The importance of the FSH concentration in initiating follicular growth in polycystic ovary-like disease.
    van Weissenbruch MM, Schoemaker HC, Drexhage HA, Schoemaker J.
    Hum Reprod; 1993 Jun 20; 8(6):813-21. PubMed ID: 8345068
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.